DALLAS WRIGHT: Open Payments
NPI 1841776333 · JASPER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,612 in 108 payments from 39 companies in 2025. Trend: 2023 $116 · 2024 $1,190 · 2025 $2,612
Food & beverage: $2,512Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $431 |
| AstraZeneca Pharmaceuticals LP | 8 | $195 |
| Merck Sharp & Dohme LLC | 8 | $157 |
| Janssen Biotech, Inc. | 6 | $137 |
| Celgene Corporation | 6 | $137 |
| Eisai Inc. | 5 | $125 |
| SEAGEN INC. | 1 | $100 |
| BeOne Medicines USA, Inc. | 4 | $89 |
| TerSera Therapeutics LLC | 3 | $84 |
| Aveo Pharmaceuticals, Inc. | 2 | $72 |
Products named: KISQALI, REBLOZYL, KEYTRUDA, Lenvima, Fabhalta, FOTIVDA, TEVIMBRA, Enhertu.
Industry payments across GA — which companies pay providers there.
